Popular Articles

U.S. Marshals Seize Drug Products Manufactured By Caraco Pharmaceutical Laboratories Ltd. FDA Acts To Prevent Repeated Drug Quality Problems
U.S. Marshals, at the request of the Food and Drug Administration, today seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. (Caraco), at the company"s Michigan facilities in Detroit, Farmington Hills, and Wixom. The seizure also includes ingredients held at these same facilities. "The FDA is committed to taking enforcement action against firms that do not manufacture drugs in accordance with our good manufacturing practice requirements," said Janet Woodcock, M.D., director of the FDA"s Center for Drug Evaluation and Research. "Compliance with these standards prevents harm to the public."

DCP Comments On New Horizons - British Psychological Society
The British Psychological Society has welcomed the publication, of New Horizons, the government"s new plan for the development of mental health services.
News of the day
RISPERDAL(R) CONSTA(R) (Risperidone) Long-Acting Treatment Delayed The Time To Relapse In Patients With Bipolar I Disorder
New data demonstrate that maintenance therapy with RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to placebo in patients with Bipolar I Disorder. Results of the study were presented this week at a major medical meeting.
Endocrinology

Infectious Diseases Remain A Burden To Healthcare Systems Worldwide

Respiratory infectious diseases continue to be a huge and rising burden to health-care systems and societies worldwide. Published by Wiley-Blackwell, the latest issue of Respirology includes an invited review series focused on infectious pulmonary diseases. The first paper entitled "Clinical Challenges in Managing Bronchiectasis" provides a review of the characteristics and clinical features of Bronchiectasis. The article also includes the often misdiagnosed and neglected treatment guidelines on how best to manage this common disease. Lead author Kenneth Tsang from the LKS Faculty of Medicine, The University of Hong Kong said, "As symptoms of bronchiectasis are not specific, many patients are misdiagnosed as suffering from other inflammatory airway diseases such as asthma and COPD. Despite being prevalent in Asia-Pacific, bronchiectasis remains a long-neglected illness which should receive more research attention for better understanding of its aetiology, pathogenesis and treatment." Another paper in the series, "Respiratory Infections: A Current and Future Threat", focuses on human pulmonary pathogens and environmental factors that contribute to the continued global burden of respiratory diseases. The evolution and adaptation of human pathogens, in order to overcome immune responses, mean that new therapeutic and diagnostic approaches are necessary to combat viral threats. Coupled with clinical vigilance and strict infection control, the burden of pulmonary infection disease may then stand the chance of being reduced. Wiley - Blackwell


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):